Abstract:Respiratory syncytial virus (RSV) and influenza are among the most important causes of severe respiratory disease worldwide. Despite the clinical need, barriers to developing reliably effective vaccines against these viruses have remained firmly in place for decades. Overcoming these hurdles requires better understanding of human immunity and the strategies by which these pathogens evade it. Although superficially similar, the virology and host response to RSV and influenza are strikingly distinct. Influenza induces robust strain-specific immunity following natural infection, although protection by current vaccines is short-lived. In contrast, even strain-specific protection is incomplete after RSV and there are currently no licensed RSV vaccines. Although animal models have been critical for developing a fundamental understanding of antiviral immunity, extrapolating to human disease has been problematic. It is only with recent translational advances (such as controlled human infection models and high-dimensional technologies) that the mechanisms responsible for differences in protection against RSV compared to influenza have begun to be elucidated in the human context. Influenza infection elicits high-affinity IgA in the respiratory tract and virus-specific IgG, which correlates with protection. Long-lived influenza-specific T cells have also been shown to ameliorate disease. This robust immunity promotes rapid emergence of antigenic variants leading to immune escape. RSV differs markedly, as reinfection with similar strains occurs despite natural infection inducing high levels of antibody against conserved antigens. The immunomodulatory mechanisms of RSV are thus highly effective in inhibiting long-term protection, with disturbance of type I interferon signaling, antigen presentation and chemokine-induced inflammation possibly all contributing. These lead to widespread effects on adaptive immunity with impaired B cell memory and reduced T cell generation and functionality. Here, we discuss the differences in clinical outcome and immune response following influenza and RSV. Specifically, we focus on differences in their recognition by innate immunity; the strategies used by each virus to evade these early immune responses; and effects across the innate-adaptive interface that may prevent long-lived memory generation. Thus, by comparing these globally important pathogens, we highlight mechanisms by which optimal antiviral immunity may be better induced and discuss the potential for these insights to inform novel vaccines.

The Immune Response to Respiratory Viruses: From Start to Memory

Innate Immune Memory Of Tissue-Resident Macrophages And Trained Innate Immunity: Re-Vamping Vaccine Concept And Strategies

Immune Response to Respiratory Viral Infections

Induction of Autonomous Memory Alveolar Macrophages Requires T Cell Help and is Critical to Trained Immunity

Current Insights into the Host Immune Response to Respiratory Viral Infections

Diverging patterns in innate immunity against respiratory viruses during a lifetime: lessons from the young and the old

Tissue resident memory T cells in the respiratory tract

Inflammatory response to SARS-CoV 2 and other respiratory viruses

Viral infection of the lung: host response and sequelae

Acute and Chronic Airway Responses to Viral Infection

Pulmonary resident memory T cells in respiratory virus infection and their inspiration on therapeutic strategies

Innate Immune Evasion by Human Respiratory RNA Viruses

The CD8 T Cell Response to Respiratory Virus Infections

Primary nasal viral infection rewires the tissue-scale memory response

Tissue‐resident memory T cells and lung immunopathology

Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus

Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract

Cellular and Molecular Immunity to Influenza Viruses and Vaccines

Ingestion, Immunity, and Infection: Nutrition and Viral Respiratory Tract Infections

Temporal High-Resolution Atlas of Human Blood Leukocyte Composition in Response to Respiratory Virus Inoculation

Innate immune responses to respiratory syncytial virus infection